how successful is chemotherapy for small cell lung cancer - Sports Zone
Researchers have built an AI-powered pathology tool designed to predict whether small cell lung cancer patients will respond to platinum-based chemotherapy, a first-line treatment that works well for ... EurekAlert!: Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: Another weapon in the armamentarium Perioperative toripalimab and chemotherapy in resectable non-small cell lung cancer: Another weapon in the armamentarium Imdelltra significantly improved progression-free and overall survival compared to chemotherapy in small cell lung cancer patients, with a median overall survival of 13.6 months versus 8.3 months. The ...
Understanding the Context
Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ... Morning Overview on MSN: New AI tool aims to predict small cell lung cancer treatment response New AI tool aims to predict small cell lung cancer treatment response Medical Xpress on MSN: New AI tool predicts whether aggressive small cell lung cancer will respond to treatment